SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001358403-18-000099
Filing Date
2018-11-06
Accepted
2018-11-06 16:17:11
Documents
61
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a2018q310q.htm 10-Q 1094816
2 EXHIBIT 31.1 exh3112018q3.htm EX-31.1 13211
3 EXHIBIT 31.2 exh3122018q3.htm EX-31.2 13395
4 EXHIBIT 32.1 exh3212018q3.htm EX-32.1 11403
  Complete submission text file 0001358403-18-000099.txt   4754080

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT blcm-20180930.xml EX-101.INS 881822
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blcm-20180930.xsd EX-101.SCH 33759
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT blcm-20180930_cal.xml EX-101.CAL 60584
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT blcm-20180930_def.xml EX-101.DEF 163118
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blcm-20180930_lab.xml EX-101.LAB 489628
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blcm-20180930_pre.xml EX-101.PRE 283231
Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030
Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36783 | Film No.: 181163201
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1